Rubicon Technology Stock Price, News & Analysis

Rubicon Technology, Inc. (RBCN) is associated with advanced materials and related businesses and trades on the over-the-counter (OTC) market. According to company disclosures in multiple press releases, Rubicon operates through wholly owned subsidiaries that focus on monocrystalline sapphire products for optical systems and specialty electronic devices, as well as a specialized pharmacy business. More recently, Rubicon has also completed the acquisition of a logistics management company, adding cargo transportation logistics services to its operations.

Rubicon has stated that its subsidiary Rubicon Technology Worldwide LLC is an advanced materials provider specializing in monocrystalline sapphire products for optical systems and specialty electronic devices. The company describes having expertise that extends from the preparation of raw aluminum oxide through sapphire crystal growth and fabrication, which enables it to supply custom sapphire products with a focus on quality and precision. Rubicon has also reported that this business is ISO 9001 certified and ITAR registered.

Another Rubicon subsidiary, Rubicon DTP LLC doing business as Direct Dose Rx, is described as a specialized pharmacy. Based on the company’s own description, Direct Dose Rx provides prescription medications, over-the-counter drugs and vitamins to patients being discharged from skilled nursing facilities and hospitals, and to retail customers who want medications delivered to their home. The products are delivered in perforated strip-packaging, sorted by dose, date and time to be taken, rather than in separate pill bottles. Rubicon has indicated that Direct Dose Rx is licensed to operate in multiple states and that its services are intended to benefit patients and healthcare facilities by reducing the risk of hospital readmissions.

Rubicon has also publicly discussed its tax attributes, noting substantial net operating loss carryforwards for U.S. federal income tax purposes. To protect the potential value of these tax assets, the company entered into a Section 382 Rights Agreement and later extended that agreement. Rubicon has explained that this rights plan was adopted in an effort to preserve stockholder value by protecting against a possible limitation on the company’s ability to use its net operating loss carryforwards. The company has also indicated that it has explored alternatives to enhance stockholder value, including potential acquisitions, new ventures or other investment opportunities that could utilize these net operating losses.

In corporate actions, Rubicon has announced stock repurchase plans authorized by its board of directors to repurchase shares of its common stock through open market and private transactions. The company has described these repurchases as a use of capital following the sale of certain assets and consolidation of operating facilities. Rubicon has also been involved in transactions with Janel Corporation, including a cash tender offer for a significant portion of Rubicon’s outstanding common stock and related cash distributions to Rubicon stockholders.

Rubicon has reported that it voluntarily chose to delist from the Nasdaq Capital Market, indicating its intent to file a Form 25 with the U.S. Securities and Exchange Commission and move trading of its common stock to an OTC platform. The company cited factors such as the expenses of being listed on Nasdaq and the demands on management’s time associated with Nasdaq listing standards as reasons for this decision. Rubicon has stated that it anticipated quotation of its common stock on the Pink Sheets platform operated by OTC Markets Group Inc. and that it intended to take actions within its control to enable continued quotation, while noting that there is no guarantee a broker will continue to make a market in the stock.

A significant development disclosed by Rubicon is its acquisition of Janel Group LLC. According to joint announcements by Rubicon and Janel Corporation, Rubicon entered into a definitive merger agreement and subsequently completed the transaction under which Janel Group became a wholly owned subsidiary of Rubicon. Janel Group is described as a non-asset based, full-service provider of cargo transportation logistics management services. The company’s services, as described in Rubicon’s and Janel’s releases, include freight forwarding via air, ocean and land-based carriers; customs brokerage services; warehousing and distribution services; trucking; and other value-added logistics services. Janel Group operates in the United States with over 25 locations and serves customers globally through networks of international partners.

Rubicon has stated that this transaction allows it to acquire a profitable business and gain better access to capital. In connection with the acquisition, Rubicon agreed to issue shares of its common stock to Janel Corporation and to assume certain indebtedness and net working capital liabilities of Janel Group, while gaining access to borrowing capacity under an existing credit facility. As a result of these transactions, Janel Corporation disclosed that it owns a substantial majority of Rubicon’s common stock, and the parties have referenced an existing governance, nomination and voting agreement addressing related party transactions between Rubicon and Janel Corporation and its affiliates.

Across these disclosures, Rubicon portrays itself as a company with activities in advanced materials, specialized pharmacy services, and logistics management, supported by significant tax attributes and a history of capital structure transactions. Its shares have transitioned from a Nasdaq listing to trading on OTC markets, and its ownership structure has been significantly influenced by transactions with Janel Corporation.

Business segments and activities

• Advanced materials (sapphire products): Through Rubicon Technology Worldwide LLC, the company focuses on monocrystalline sapphire products for optical systems and specialty electronic devices, with capabilities from raw aluminum oxide preparation through crystal growth and fabrication.
• Specialized pharmacy services: Through Rubicon DTP LLC (Direct Dose Rx), Rubicon provides prescription medications, over-the-counter drugs and vitamins in dose-sorted strip-packaging to patients and retail customers, with operations licensed in multiple states.
• Logistics management: Through the acquired Janel Group LLC, Rubicon is associated with cargo transportation logistics management services, including freight forwarding, customs brokerage, warehousing and distribution, trucking and related logistics services.
• Capital and tax planning: The company has highlighted its net operating loss carryforwards and has implemented a Section 382 Rights Agreement and other measures, such as stock repurchase plans and corporate transactions, in part with reference to stockholder value and the use of these tax attributes.

Trading status and ownership context

Rubicon has publicly announced that its common stock was voluntarily delisted from the Nasdaq Capital Market following the filing of a Form 25 and that it expected its shares to be quoted on an OTC platform. The company has also disclosed that it received Nasdaq notifications regarding independent director requirements prior to its delisting decision. In addition, Rubicon and Janel Corporation have reported that, through tender offers and share issuances related to the Janel Group acquisition, Janel Corporation came to own a substantial majority of Rubicon’s outstanding common stock.

RBCN stock overview on Stock Titan

On Stock Titan, the RBCN overview page brings together the available information about Rubicon’s business activities, its subsidiaries in advanced materials, specialized pharmacy services and logistics management, and its trading status on OTC markets. Investors and researchers can use this context to better understand how Rubicon describes its operations, how past corporate actions have affected its capital structure, and how the acquisition of Janel Group LLC fits into the company’s stated efforts to enhance stockholder value and utilize its net operating losses.

FAQs about Rubicon Technology, Inc. (RBCN)